"10.1371_journal.ppat.1005369","plos pathogens","2016-01-14T00:00:00Z","Elise Landais; Xiayu Huang; Colin Havenar-Daughton; Ben Murrell; Matt A Price; Lalinda Wickramasinghe; Alejandra Ramos; Charoan B Bian; Melissa Simek; Susan Allen; Etienne Karita; William Kilembe; Shabir Lakhi; Mubiana Inambao; Anatoli Kamali; Eduard J Sanders; Omu Anzala; Vinodh Edward; Linda-Gail Bekker; Jianming Tang; Jill Gilmour; Sergei L Kosakovsky-Pond; Pham Phung; Terri Wrin; Shane Crotty; Adam Godzik; Pascal Poignard","International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Center, La Jolla, California, United States of America; Sanford-Burnham Medical Research Institute, La Jolla, California, United States of America; La Jolla Institute for Allergy and Immunology (LIAI), La Jolla, California, United States of America; Department of Medicine, University of California San Diego, San Diego, California, United States of America; IAVI Medical Affairs, New York, New York, United States of America; University of California San Francisco Department of Epidemiology and Biostatistics, San Francisco, California, United States of America; Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia, United States of America; Rwanda-Zambia HIV Research Group, Lusaka & Ndola, Zambia; Rwanda-Zambia HIV Research Group, Project San Francisco, Kigali, Rwanda; MRC/UVRI Uganda Research Unit on AIDS, Masaka & Entebbe, Uganda; Centre for Geographic Medicine-Coast, Kenya Medical Research Institute, Kilifi, Kenya; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; Kenya AIDS Vaccine Initiative, Nairobi, Kenya; The Aurum Institute, Parktown, Johannesburg, South Africa; Desmond Tutu HIV Center, University of Cape Town, Cape Town, South Africa; University of Alabama Birmingham, Department of Epidemiology and Department of Medicine, Birmingham, Alabama, United States of America; IAVI Human Immunology Laboratory, Imperial College of Science Technology and Medicine, Chelsea & Westminster Hospital, London, United Kingdom; Monogram Biosciences, Laboratory Corporation of AmericaÂ® Holdings, San Francisco California, United States of America; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID), La Jolla, California, United States of America; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, United States of America","Conceived and designed the experiments: EL CHD SC PPo. Performed the experiments: EL CHD LW AR CBB PPh TW. Analyzed the data: EL XH CHD BM MAP SLKP PPh TW SC AG PPo. Wrote the paper: EL XH SC PPo. Established the cohort and managed samples and clinical data used in this study: MAP MS SA EK WK SL MI AK EJS OA VE LGB JG. Provided the HLA typing data: JT.","PPh and TW are employed by a commercial company, Monogram Biosciences, Inc. This affiliation does not alter our adherence to all the PLOS Pathogens policies on sharing data and materials. The other authors have declared that no competing interests exist.","2016","01","Elise Landais","EL",27,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
